I’m sure all of you have heard the 12 Days of Christmas song. It is the holiday equivalent of 99 Bottles of Beer on the Wall, and no one ever sings it to completion because it’s so long.
But it does raise the question, what are the 12 days of Christmas? Why are there 12? And why am I doing an episode on this in January well after Christmas is over?
Learn the answers to these questions on the episode of Everything Everywhere Daily.
This week’s theme, courtesy of Tony Soprano: “Is the U.S. over?”
Both Tammy and Jay have new pieces out on our failure to curb the spread of Covid-19 in nursing homes. The country has seemed unable to tackle complex problems. Have we learned anything? What now?
23:45 – At the end of 2020, Beijing-based economic analyst Dan Wang offered this year-in-review newsletter full of global, historical observations of the U.S., spurring much chatter on China Twitter.
Is Chinese society experiencing the equivalent of the U.S.’s “golden age of capitalism”? How do most Americans imagine the life of an “average” person in China—you know, like Pangzai? And is the U.S. in a “declining empire” / “rentier” stage of its history?
1:09:30 – A listener question from Swoo: What were some of your favorite reads in 2020?
Election Day in Georgia with control of the Senate up for grabs. Republicans protest the results of the Presidential election. Pharmacist accused of vaccine destruction in court. CBS News Correspondent Steve Kathan has today's World News Roundup.
I review a handful of choices you have if you want to give money to kids. 2020 review. I go over the year end numbers for a variety of stock and bond funds.
It is no surprise that more-transmissible coronavirus variants are cropping up. We ask how worrisome the strains found in Britain and South Africa are. American authorities have lodged a landmark case against Walmart for its role in the country’s worsening opioid crisis—a problem with clearly more than one cause. And dealing with the pile of unused vacation days from 2020.
Sophy Lee was born in China, but grew up in a lot of countries and places. She grew up in Australia, lived all over Texas, and went to Harvard for undergrad, studying economics. She is an avid bike racer, mainly on the road, and a triathlete. The combination of living in difference places, school, and racing lead her into the tech world. In fact, she moved to San Francisco to race - though he had taught herself to program post college and had an idea brewing in her head on how to become a better engineer in San Fran.
Sophy has been working on her current product for 6.5 years, starting at a different company formerly known as Shuttle. The product was built originally to map out a trip from point a to b, and have a driver give a protected ride to a child. Four years ago, her current company acquired the product, at which point she joined as CTO to lead the Technology & Information Security team.
So far, the vaccine roll out in the United States has been underwhelming. States are scrambling to get doses out to patients before they expire. We won’t be behind schedule on vaccine distribution forever, but to make matters worse, a more infectious variant of COVID-19 has increased the urgency.
Guest: Apoorva Mandavilli is a health and science reporter with the New York Times.
Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.
Word that Jack Dorsey’s Square is talking to Jay-Z about acquiring Tidal isn’t the most shocking thing we’ve ever heard, now that we’ve digested it. General Electric’s stock has one great final hope: A fan that’s as big as the Empire State Building. And Discovery jumps into subscripturation, but it’s got the QQE recipe.
$SQ $GE $DISCA
Got a SnackFact? Tweet it @RobinhoodSnacks @TBOYJack @NickOfNewYork
Want a shoutout on the pod? Fill out this form:
https://forms.gle/KhUAo31xmkSdeynD9
Learn more about your ad choices. Visit podcastchoices.com/adchoices
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
So far, the vaccine roll out in the United States has been underwhelming. States are scrambling to get doses out to patients before they expire. We won’t be behind schedule on vaccine distribution forever, but to make matters worse, a more infectious variant of COVID-19 has increased the urgency.
Guest: Apoorva Mandavilli is a health and science reporter with the New York Times.
Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.
When a company in your portfolio holds a conference call with analysts, is the call in the morning or afternoon? As best-selling author Dan Pink writes in his book When: The Scientific Secrets of Perfect Timing, the answer matters more than you think.
